0000000001164414

AUTHOR

Mark Larkin

showing 1 related works from this author

Patient-reported impact of Charcot-Marie-Tooth disease: protocol for a real-world digital lifestyle study

2021

Abstract Background Charcot-Marie-Tooth disease (CMT) is a rare, chronic, progressive motor and sensory neuropathy that affects the peripheral nervous system, leading to progressive, predominantly distal muscle weakness, atrophy, sensory loss and progressive limb dysfunction. As with many rare diseases, there is a lack of patient-reported data with which to understand and address patient needs. This study aims to explore the real-world impact of CMT from the patient perspective. Methods This is a prospective, digital lifestyle study of at least 2,000 people with CMT, >18 years, resident in the following countries: France, Germany, Italy, Spain, the UK and the USA. Participants will be re…

Malecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyDemographicsDiseaseUnmet needs03 medical and health sciencesTooth disease0302 clinical medicinePhysical medicine and rehabilitationCharcot-Marie-Tooth DiseaseMedicineHumans030212 general & internal medicineobservationalPatient Reported Outcome MeasuresProspective StudiesLife StyleSelection (genetic algorithm)Protocol (science)business.industryIdentifierpatient-reported outcomesinternationalburden of illnessObservational studyFemaleNeurology (clinical)business030217 neurology & neurosurgery
researchProduct